Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schulz

Showing results (201-210 of 835) with videos related to

Pageof 84
Sort By:
BMJ (Clinical Research Ed.)|February 16, 2017
Harms of outcome switching in reports of randomised trials: CONSORT perspectiveDouglas G Altman, David Moher, Kenneth F Schulz
Medizinische Klinik (Klinik-Ausg.)|January 1, 1982
[ACTH response in the dexamethasone suppression test]E Jungmann, F Schulz, W Magnet, et al.
Statistics in Medicine|August 21, 2012
Improving the reporting of randomised trials: the CONSORT Statement and beyondDouglas G Altman, David Moher, Kenneth F Schulz
Annals of Internal Medicine|March 26, 2010
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trialsKenneth F Schulz, Douglas G Altman, David Moher, et al.
BMJ (Clinical Research Ed.)|March 25, 2010
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trialsKenneth F Schulz, Douglas G Altman, David Moher, et al.
Schmerz (Berlin, Germany)|February 9, 2005
[CONSORT statement. Revised findings on quality improvement based on reports from randomized studies in parallel design]D Moher, K F Schulz, D G Altman, et al.
Current HIV/AIDS Reports|August 11, 2005
Human herpesvirus 8: biology and role in the pathogenesis of Kaposi's sarcoma and other AIDS-related malignanciesAbel Viejo-Borbolla, Matthias Ottinger, Thomas F Schulz
Wiener Klinische Wochenschrift|March 1, 1985
[Localization of functionally important areas of the regulator protein factor H using monoclonal antibodies]T F Schulz, J Alsenz, M P Dierich
Current Opinion in Virology|June 18, 2023
Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen: more than a key mediator of viral persistenceThomas F Schulz, Anika Freise, Saskia C Stein
Journal of Virology|April 28, 2017
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral PersistenceMagdalena Weidner-Glunde, Giuseppe Mariggiò, Thomas F Schulz
Pageof 84

Showing results (201-210 of 835) with videos related to

Sort By:
Pageof 84
BMJ (Clinical Research Ed.)|February 16, 2017
Harms of outcome switching in reports of randomised trials: CONSORT perspectiveDouglas G Altman, David Moher, Kenneth F Schulz
Medizinische Klinik (Klinik-Ausg.)|January 1, 1982
[ACTH response in the dexamethasone suppression test]E Jungmann, F Schulz, W Magnet, et al.
Statistics in Medicine|August 21, 2012
Improving the reporting of randomised trials: the CONSORT Statement and beyondDouglas G Altman, David Moher, Kenneth F Schulz
Annals of Internal Medicine|March 26, 2010
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trialsKenneth F Schulz, Douglas G Altman, David Moher, et al.
BMJ (Clinical Research Ed.)|March 25, 2010
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trialsKenneth F Schulz, Douglas G Altman, David Moher, et al.
Schmerz (Berlin, Germany)|February 9, 2005
[CONSORT statement. Revised findings on quality improvement based on reports from randomized studies in parallel design]D Moher, K F Schulz, D G Altman, et al.
Current HIV/AIDS Reports|August 11, 2005
Human herpesvirus 8: biology and role in the pathogenesis of Kaposi's sarcoma and other AIDS-related malignanciesAbel Viejo-Borbolla, Matthias Ottinger, Thomas F Schulz
Wiener Klinische Wochenschrift|March 1, 1985
[Localization of functionally important areas of the regulator protein factor H using monoclonal antibodies]T F Schulz, J Alsenz, M P Dierich
Current Opinion in Virology|June 18, 2023
Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen: more than a key mediator of viral persistenceThomas F Schulz, Anika Freise, Saskia C Stein
Journal of Virology|April 28, 2017
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral PersistenceMagdalena Weidner-Glunde, Giuseppe Mariggiò, Thomas F Schulz
Pageof 84